Source comparison
Comparison: Appetite-Modulating Research Peptides
To put BPC 157's subtle, indirect effects into perspective, it's helpful to compare it to other peptides where appetite modulation is a primary, direct effect. Our team put together this quick reference table to highlight the stark differences in mechanisms. B
This comparison does not assign a generated winner or score.
- To put BPC 157's subtle, indirect effects into perspective, it's helpful to compare it to other peptides where appetite modulation is a primary, direct effect. Our team put together this quick reference table to highlight the stark differences in mechanisms.
- BPC 157
- Indirect: Gut health, healing demands, neurotransmitter balance.
- Neutral to slight, variable increase; often a 'normalization' of appetite.
- BPC 157 Peptide
- GHRP-6
- Direct: Potent ghrelin mimetic, directly signals the brain to eat.
- Strong, often dramatic and immediate increase in hunger.
- Ghrp 6
- CJC-1295 / Ipamorelin
- Indirect: GHRH/GHRP that stimulates GH with little ghrelin impact.
- Minimal to no direct effect on appetite is typically observed.
- CJC1295 Ipamorelin 5MG 5MG
- Tesofensine
- Direct: Inhibits reuptake of dopamine, serotonin, and noradrenaline.
- Strong and consistent appetite suppression; feeling of fullness.
- Tirzepatide
- Direct: Dual GLP-1/GIP receptor agonist.
- Significant appetite suppression, delayed gastric emptying, reduced cravings.
- As you can see, BPC 157 is in a completely different category. It’s not designed as a tool for appetite manipulation. Any changes are a byproduct of its powerful systemic effects, which is a critical distinction for any researcher to make.